United States· US:0642-7463_5a0a4918-baac-1b17-e063-6294a90a781b

Benznidazole

A benznidazole product containing benznidazole, registered in United States by Exeltis USA, Inc.. The same ATC class is registered in 2 of our 19 countries.

ATC P01CA02

Checked against FDA National Drug Code directory (United States) on

Informational only — not a medical device.

SOURCE REGISTER · USFDA National Drug Code directory (Unite…normalisedBenznidazoleATCP01CA02REGISTER NO.US:0642-7463_5a0a4918…PACKS LISTED1CHECKEDSeptember 27, 2026

Where it is registered

Benznidazole is registered in 2 of 19 countries.

Countries holding a registration under ATC P01CA02 (benznidazole), each read from that country’s own register.

  • This record: United States, from FDA National Drug Code directory (United States)
  • 1 of them publish a price we can compare per daily dose

Benznidazole · ATC P01CA02

2 / 19 countries

  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

FDA National Drug Code directory (United States)
Active substance
BENZNIDAZOLE
Manufacturer
Exeltis USA, Inc.
Country
United States (US)
ATC code
P01CA02
ATC class
Benznidazole
Defined daily dose
0.4 g, O
Reimbursed
Not published by this register
Source register
FDA National Drug Code directory (United States)
Last checked
September 27, 2026

Packs & prices · 1

  • ndc11
    0642-7463-12

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

107 interactions on record for benznidazole.

Graded by severity as the source publishes them — 7 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Benznidazole · interactions on record

107 records

  • 7 severe
  • 100 moderate

Most severe, free to view

  • EthanolB05XX04severe
  • AmprenavirJ05AE05severe
  • DisulfiramN07BB01severe
  • DisulfiramP03AA04severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Benznidazole in 1 other country

What each register calls a product with the same active substance — salts and hydrates count as the same.

All benznidazole products

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/032f49ae-3999-454f-98ea-585b0109c262
GET /v1/drugs/032f49ae-3999-454f-98ea-585b0109c262?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "route": "ORAL",
  "source": "ndc",
  "strength": "12.5",
  "substance": "BENZNIDAZOLE",
  "productndc": "0642-7463",
  "dosage_form": "TABLET",
  "dea_schedule": null,
  "strength_unit": "mg/1",
  "application_number": "NDA209570",
  "marketing_category": "NDA"
}

See everything about benznidazole.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.